Escalating cases of organ shortage and donor scarcity worldwide are alarming reminders of
the need for alternatives to allograft tissues. Within the last three decades, research efforts in …

Abstract Three-dimensional (3D) bioprinting, an additive manufacturing based technique of
biomaterials fabrication, is an innovative and auspicious strategy in medical and …

Directed differentiation of human pluripotent stem cells to kidney organoids brings the
prospect of drug screening, disease modelling and the generation of tissue for renal …

Predicting the effects of drugs before human clinical trials is at the heart of drug screening
and discovery processes. The cost of drug discovery is steadily increasing owing to the …

This bioprinting roadmap features salient advances in selected applications of the technique
and highlights the status of current developments and challenges, as well as envisioned …

The encapsulation of cells within gel‐phase materials to form bioinks offers distinct
advantages for next‐generation 3D bioprinting. 3D bioprinting has emerged as a promising …

Additive manufacturing (AM) alias 3D printing translates computer-aided design (CAD)
virtual 3D models into physical objects. By digital slicing of CAD, 3D scan, or tomography …

Abstract 3D bioprinting is a pioneering technology that enables fabrication of biomimetic,
multiscale, multi-cellular tissues with highly complex tissue microenvironment, intricate …

Advances in three-dimensional (3D) printing have increased feasibility towards the
synthesis of living tissues. Known as 3D bioprinting, this technology involves the precise …

Bioprinting is a process based on additive manufacturing from materials containing living
cells. These materials, often referred to as bioink, are based on cytocompatible hydrogel …